Dáil Éireann Debate, Tuesday - 2 November 2021
1147. Deputy Róisín Shortall asked the Minister for Health the details of the quantities of mRNA vaccines currently in stock; the schedule of expected deliveries and quantities between now and the end of 2021; and if he will make a statement on the matter. [53381/21]
View answerIreland has entered into seven Advance Purchase Agreements, subject to regulatory approval, for the purchase of Covid-19 vaccine from a range of manufacturers. Four vaccines have been authorised by the European Medicines Agency to date; Comirnaty (Pfizer/BioNTech), Spikevax (Moderna), Vaxzevria (AstraZeneca) and Janssen.
As of 25 October, over 7.48 million doses of the four approved vaccines have been administered since the programme commenced in December 2020. 91.6% of the eligible population have now received a vaccine dose with in excess of 90% having been fully vaccinated.
The following table provides an overview of the quantity of mRNA vaccines by manufacturer administered in the vaccination programme.
Overview of Authorised mRNA Covid Vaccines Supply Procured and Administered for Ireland (In Millions)
|
Vaccine Manufacturer |
Amount administered – 25.10.21 |
|
Pfizer/BioNTech |
5.3 |
|
Moderna |
0.57 |
|
Total |
5.87 |
Ireland has procured significant quantities of vaccines to facilitate the continuation of the Covid-19 vaccination programme and the continued rollout of the booster programme over the coming months. The specific delivery schedules of individual manufactures to year-end are yet to be confirmed.
